[Novobiocin; its experimental activity in vitro and in vivo; its value in severe staphylococcal diseases].
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D004696:Endocarditis; D004697:Endocarditis, Bacterial / Q000209:etiology*; D066298:In Vitro Techniques; D008837:Micrococcus / Q000187:drug effects* / Q000472:pathogenicity* / Q000628:therapy*; D009675:Novobiocin; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D009675:Novobiocin
ANTIBIOTICS/effects; ANTIBIOTICS/therapeutic use; ENDOCARDITIS, BACTERIAL/etiology and pathogenesis; MICROCOCCAL INFECTIONS/therapy; MICROCOCCUS PYOGENES/effect of drugs on
La novobiocine; son activité expérimentale in vitro et in vivo; son intérêt dans les affections graves à staphylocoques.